Page last updated: 2024-10-20

pyrazinamide and Dermatitis, Contact, Phototoxic

pyrazinamide has been researched along with Dermatitis, Contact, Phototoxic in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research Excerpts

ExcerptRelevanceReference
"Pyrazinamide was able to cause photohemolysis in human erythrocytes and peroxidation of linoleic acid."1.32Photodegradation pathways and the in vitro phototoxicity of pyrazinamide, a phototoxic antitubercular drug. ( Díaz, Y; Fuentes, A; Rivas, C; Vargas, F, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vargas, F1
Rivas, C1
Díaz, Y1
Fuentes, A1
Choonhakarn, C1
Janma, J1

Other Studies

2 other studies available for pyrazinamide and Dermatitis, Contact, Phototoxic

ArticleYear
Photodegradation pathways and the in vitro phototoxicity of pyrazinamide, a phototoxic antitubercular drug.
    Journal of photochemistry and photobiology. B, Biology, 2003, Dec-05, Volume: 72, Issue:1-3

    Topics: Antitubercular Agents; Dermatitis, Phototoxic; Erythrocytes; Humans; Photolysis; Pyrazinamide; Ultra

2003
Pyrazinamide-induced lichenoid photodermatitis.
    Journal of the American Academy of Dermatology, 1999, Volume: 40, Issue:4

    Topics: Antitubercular Agents; Dermatitis, Phototoxic; Dose-Response Relationship, Drug; Drug Eruptions; Dru

1999